SlideShare une entreprise Scribd logo
1  sur  12
How can things change? By implementing a comprehensive approach to rare diseases By developing appropriate public health policies By increasing international cooperation in scientific research By gaining and sharing scientific knowledge about all rare diseases, not only the most “frequent” ones By developing new diagnostic and therapeutic procedures By raising public awareness By facilitating the network of patient groups to share their experience and best practices By supporting the most isolated patients and their parents to create new patient communities or patient groups By providing comprehensive quality information to the rare disease community Source: Eurordis
By implementing a comprehensive approach to rare diseases
 
By developing appropriate public health policies
 
 
By gaining and sharing scientific knowledge about all rare diseases, not only the most  “frequent” ones By developing new diagnostic and therapeutic procedures
 
By gaining and sharing scientific knowledge about all rare diseases, not only the most  “frequent” ones By developing new diagnostic and therapeutic procedures
By raising public awareness By facilitating the network of patient groups to share their experience and best practices
By supporting the most isolated patients and their parents to create new patient communities  or patient groups
Thanks for your atention Thanks! More Questions???

Contenu connexe

Tendances

2010 11 13 european cme forum jan geissler 1.5
2010 11 13 european cme forum jan geissler 1.52010 11 13 european cme forum jan geissler 1.5
2010 11 13 european cme forum jan geissler 1.5jangeissler
 
Stratified Medicine Public Dialogue Case Study Part 3
Stratified Medicine Public Dialogue Case Study Part 3Stratified Medicine Public Dialogue Case Study Part 3
Stratified Medicine Public Dialogue Case Study Part 3InvolveReema
 
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)Nowgen
 
Simon denegri bristol-website
Simon denegri bristol-websiteSimon denegri bristol-website
Simon denegri bristol-websiteDeNDRoN-Comms
 
Safer patients, better care through never events, research and education cent...
Safer patients, better care through never events, research and education cent...Safer patients, better care through never events, research and education cent...
Safer patients, better care through never events, research and education cent...Canadian Patient Safety Institute
 
Carolyn Wallace WSSPR - PRIME Annual Meeting 2020
Carolyn Wallace WSSPR - PRIME Annual Meeting 2020Carolyn Wallace WSSPR - PRIME Annual Meeting 2020
Carolyn Wallace WSSPR - PRIME Annual Meeting 2020angewatkins
 
Patient Focus within Healthcare Congresses
Patient Focus within Healthcare CongressesPatient Focus within Healthcare Congresses
Patient Focus within Healthcare CongressesPYA, P.C.
 
AIDS2016 Lessons
AIDS2016 LessonsAIDS2016 Lessons
AIDS2016 Lessonsskmosher
 
Cadth 2015 c5 2. lacaze cadth symposium 2015 powerpoint
Cadth 2015 c5 2. lacaze cadth symposium 2015 powerpointCadth 2015 c5 2. lacaze cadth symposium 2015 powerpoint
Cadth 2015 c5 2. lacaze cadth symposium 2015 powerpointCADTH Symposium
 
The FDA’s Role in the HIV/AIDS Crisis Timeline
The FDA’s Role in the HIV/AIDS Crisis TimelineThe FDA’s Role in the HIV/AIDS Crisis Timeline
The FDA’s Role in the HIV/AIDS Crisis TimelineEMMAIntl
 
HSRN workshop simon denegri - 18th June 2013
HSRN workshop   simon denegri - 18th June 2013HSRN workshop   simon denegri - 18th June 2013
HSRN workshop simon denegri - 18th June 2013Simon Denegri
 
Holiday Hunger Research & Evaluation Framework
Holiday Hunger Research & Evaluation FrameworkHoliday Hunger Research & Evaluation Framework
Holiday Hunger Research & Evaluation FrameworkRobin Beveridge
 
How to formulate a systematic review question
How to formulate a systematic review questionHow to formulate a systematic review question
How to formulate a systematic review questionILRI
 

Tendances (18)

2010 11 13 european cme forum jan geissler 1.5
2010 11 13 european cme forum jan geissler 1.52010 11 13 european cme forum jan geissler 1.5
2010 11 13 european cme forum jan geissler 1.5
 
Stratified Medicine Public Dialogue Case Study Part 3
Stratified Medicine Public Dialogue Case Study Part 3Stratified Medicine Public Dialogue Case Study Part 3
Stratified Medicine Public Dialogue Case Study Part 3
 
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)
 
How to Survive a Plague- Tim Horn
How to Survive a Plague- Tim HornHow to Survive a Plague- Tim Horn
How to Survive a Plague- Tim Horn
 
Simon denegri bristol-website
Simon denegri bristol-websiteSimon denegri bristol-website
Simon denegri bristol-website
 
Seventh National HIV Strategy: a research perspective
Seventh National HIV Strategy: a research perspectiveSeventh National HIV Strategy: a research perspective
Seventh National HIV Strategy: a research perspective
 
Conquer Silence Webcast - Deck 1 of 2
Conquer Silence Webcast - Deck 1 of 2Conquer Silence Webcast - Deck 1 of 2
Conquer Silence Webcast - Deck 1 of 2
 
Safer patients, better care through never events, research and education cent...
Safer patients, better care through never events, research and education cent...Safer patients, better care through never events, research and education cent...
Safer patients, better care through never events, research and education cent...
 
Carolyn Wallace WSSPR - PRIME Annual Meeting 2020
Carolyn Wallace WSSPR - PRIME Annual Meeting 2020Carolyn Wallace WSSPR - PRIME Annual Meeting 2020
Carolyn Wallace WSSPR - PRIME Annual Meeting 2020
 
Patient Focus within Healthcare Congresses
Patient Focus within Healthcare CongressesPatient Focus within Healthcare Congresses
Patient Focus within Healthcare Congresses
 
AIDS2016 Lessons
AIDS2016 LessonsAIDS2016 Lessons
AIDS2016 Lessons
 
Cadth 2015 c5 2. lacaze cadth symposium 2015 powerpoint
Cadth 2015 c5 2. lacaze cadth symposium 2015 powerpointCadth 2015 c5 2. lacaze cadth symposium 2015 powerpoint
Cadth 2015 c5 2. lacaze cadth symposium 2015 powerpoint
 
The FDA’s Role in the HIV/AIDS Crisis Timeline
The FDA’s Role in the HIV/AIDS Crisis TimelineThe FDA’s Role in the HIV/AIDS Crisis Timeline
The FDA’s Role in the HIV/AIDS Crisis Timeline
 
Setting: Bayou
Setting: BayouSetting: Bayou
Setting: Bayou
 
HSRN workshop simon denegri - 18th June 2013
HSRN workshop   simon denegri - 18th June 2013HSRN workshop   simon denegri - 18th June 2013
HSRN workshop simon denegri - 18th June 2013
 
Holiday Hunger Research & Evaluation Framework
Holiday Hunger Research & Evaluation FrameworkHoliday Hunger Research & Evaluation Framework
Holiday Hunger Research & Evaluation Framework
 
How to formulate a systematic review question
How to formulate a systematic review questionHow to formulate a systematic review question
How to formulate a systematic review question
 
0200 Anada Plate - Welcome to the WECAN Masterclass
0200 Anada Plate - Welcome to the WECAN Masterclass0200 Anada Plate - Welcome to the WECAN Masterclass
0200 Anada Plate - Welcome to the WECAN Masterclass
 

Similaire à Social Media-Rare Disease (Luis Luque, Manuel Armayones)

Overview of Findacure's work with fundamental disease patients
Overview of Findacure's work with fundamental disease patientsOverview of Findacure's work with fundamental disease patients
Overview of Findacure's work with fundamental disease patientsFindacure
 
8,766 days to change a life
8,766 days to change a life8,766 days to change a life
8,766 days to change a lifeSimon R. Stones
 
Hannes Smarason: Genomics: Forging Patient-Centric Communities
Hannes Smarason: Genomics: Forging Patient-Centric CommunitiesHannes Smarason: Genomics: Forging Patient-Centric Communities
Hannes Smarason: Genomics: Forging Patient-Centric CommunitiesHannes Smárason
 
Rare Disease Description (source Eurordis)
Rare Disease Description (source Eurordis)Rare Disease Description (source Eurordis)
Rare Disease Description (source Eurordis)Manuel Armayones
 
Rare Solid Cancers: An Introduction - Slide 4 - K. Redmond - Information on r...
Rare Solid Cancers: An Introduction - Slide 4 - K. Redmond - Information on r...Rare Solid Cancers: An Introduction - Slide 4 - K. Redmond - Information on r...
Rare Solid Cancers: An Introduction - Slide 4 - K. Redmond - Information on r...European School of Oncology
 
Prostate cancer nov 11, 2015
Prostate cancer   nov 11, 2015Prostate cancer   nov 11, 2015
Prostate cancer nov 11, 2015ipposi
 
Kay Parkinson - Cambridge Rare Disease Summit 2015
Kay Parkinson - Cambridge Rare Disease Summit 2015Kay Parkinson - Cambridge Rare Disease Summit 2015
Kay Parkinson - Cambridge Rare Disease Summit 2015CamRARE Disease Network
 
WONCA Europe 2011 Preconference - Group 2 Presentation
WONCA Europe 2011 Preconference - Group 2 PresentationWONCA Europe 2011 Preconference - Group 2 Presentation
WONCA Europe 2011 Preconference - Group 2 PresentationVasco da Gama Movement
 
What do people think about medicines research and development? (Starling, EUP...
What do people think about medicines research and development? (Starling, EUP...What do people think about medicines research and development? (Starling, EUP...
What do people think about medicines research and development? (Starling, EUP...Nowgen
 
In the driving seat: Health care and research led for, and by young people
 In the driving seat: Health care and research led for, and by young people In the driving seat: Health care and research led for, and by young people
In the driving seat: Health care and research led for, and by young peopleSimon R. Stones
 
Core Group Overview 3 2 2010
Core Group Overview 3 2 2010Core Group Overview 3 2 2010
Core Group Overview 3 2 2010annhjenkins
 
Rare Solid Cancers: An Introduction - Slide 5 - J. Geissler - Patient advocac...
Rare Solid Cancers: An Introduction - Slide 5 - J. Geissler - Patient advocac...Rare Solid Cancers: An Introduction - Slide 5 - J. Geissler - Patient advocac...
Rare Solid Cancers: An Introduction - Slide 5 - J. Geissler - Patient advocac...European School of Oncology
 
aids control pgram.pptNurses students jn
aids control pgram.pptNurses students jnaids control pgram.pptNurses students jn
aids control pgram.pptNurses students jnMANJUPAUL7
 
HepTREC Marketing Plan
HepTREC Marketing PlanHepTREC Marketing Plan
HepTREC Marketing Plancstam
 
1 sun 1600 zorilla 2011 national hiv prevention conference final zorrilla
1 sun 1600 zorilla 2011 national hiv prevention conference final zorrilla1 sun 1600 zorilla 2011 national hiv prevention conference final zorrilla
1 sun 1600 zorilla 2011 national hiv prevention conference final zorrillaCDC NPIN
 
1 sun 1600 zorilla 2011 national hiv prevention conference final zorrilla
1 sun 1600 zorilla 2011 national hiv prevention conference final zorrilla1 sun 1600 zorilla 2011 national hiv prevention conference final zorrilla
1 sun 1600 zorilla 2011 national hiv prevention conference final zorrillaCDC NPIN
 

Similaire à Social Media-Rare Disease (Luis Luque, Manuel Armayones) (20)

Overview of Findacure's work with fundamental disease patients
Overview of Findacure's work with fundamental disease patientsOverview of Findacure's work with fundamental disease patients
Overview of Findacure's work with fundamental disease patients
 
8,766 days to change a life
8,766 days to change a life8,766 days to change a life
8,766 days to change a life
 
Guía metabólica and the Rare Diasease Day 2012
Guía metabólica and the Rare Diasease Day 2012Guía metabólica and the Rare Diasease Day 2012
Guía metabólica and the Rare Diasease Day 2012
 
Hannes Smarason: Genomics: Forging Patient-Centric Communities
Hannes Smarason: Genomics: Forging Patient-Centric CommunitiesHannes Smarason: Genomics: Forging Patient-Centric Communities
Hannes Smarason: Genomics: Forging Patient-Centric Communities
 
Rare Disease Description (source Eurordis)
Rare Disease Description (source Eurordis)Rare Disease Description (source Eurordis)
Rare Disease Description (source Eurordis)
 
Rare Solid Cancers: An Introduction - Slide 4 - K. Redmond - Information on r...
Rare Solid Cancers: An Introduction - Slide 4 - K. Redmond - Information on r...Rare Solid Cancers: An Introduction - Slide 4 - K. Redmond - Information on r...
Rare Solid Cancers: An Introduction - Slide 4 - K. Redmond - Information on r...
 
Prostate cancer nov 11, 2015
Prostate cancer   nov 11, 2015Prostate cancer   nov 11, 2015
Prostate cancer nov 11, 2015
 
Kay Parkinson - Cambridge Rare Disease Summit 2015
Kay Parkinson - Cambridge Rare Disease Summit 2015Kay Parkinson - Cambridge Rare Disease Summit 2015
Kay Parkinson - Cambridge Rare Disease Summit 2015
 
WONCA Europe 2011 Preconference - Group 2 Presentation
WONCA Europe 2011 Preconference - Group 2 PresentationWONCA Europe 2011 Preconference - Group 2 Presentation
WONCA Europe 2011 Preconference - Group 2 Presentation
 
Global goal setting: a pathway to results 2.5 x 2025
Global goal setting: a pathway to results 2.5 x 2025Global goal setting: a pathway to results 2.5 x 2025
Global goal setting: a pathway to results 2.5 x 2025
 
What do people think about medicines research and development? (Starling, EUP...
What do people think about medicines research and development? (Starling, EUP...What do people think about medicines research and development? (Starling, EUP...
What do people think about medicines research and development? (Starling, EUP...
 
Chn Ratio
Chn RatioChn Ratio
Chn Ratio
 
In the driving seat: Health care and research led for, and by young people
 In the driving seat: Health care and research led for, and by young people In the driving seat: Health care and research led for, and by young people
In the driving seat: Health care and research led for, and by young people
 
Core Group Overview 3 2 2010
Core Group Overview 3 2 2010Core Group Overview 3 2 2010
Core Group Overview 3 2 2010
 
Rare Solid Cancers: An Introduction - Slide 5 - J. Geissler - Patient advocac...
Rare Solid Cancers: An Introduction - Slide 5 - J. Geissler - Patient advocac...Rare Solid Cancers: An Introduction - Slide 5 - J. Geissler - Patient advocac...
Rare Solid Cancers: An Introduction - Slide 5 - J. Geissler - Patient advocac...
 
aids control pgram.pptNurses students jn
aids control pgram.pptNurses students jnaids control pgram.pptNurses students jn
aids control pgram.pptNurses students jn
 
HepTREC Marketing Plan
HepTREC Marketing PlanHepTREC Marketing Plan
HepTREC Marketing Plan
 
1 sun 1600 zorilla 2011 national hiv prevention conference final zorrilla
1 sun 1600 zorilla 2011 national hiv prevention conference final zorrilla1 sun 1600 zorilla 2011 national hiv prevention conference final zorrilla
1 sun 1600 zorilla 2011 national hiv prevention conference final zorrilla
 
1 sun 1600 zorilla 2011 national hiv prevention conference final zorrilla
1 sun 1600 zorilla 2011 national hiv prevention conference final zorrilla1 sun 1600 zorilla 2011 national hiv prevention conference final zorrilla
1 sun 1600 zorilla 2011 national hiv prevention conference final zorrilla
 
Vicki Wade
Vicki WadeVicki Wade
Vicki Wade
 

Plus de Manuel Armayones

Behavior Design Lab-eHealth Center-Open University of Catalonia
Behavior Design Lab-eHealth Center-Open University of CataloniaBehavior Design Lab-eHealth Center-Open University of Catalonia
Behavior Design Lab-eHealth Center-Open University of CataloniaManuel Armayones
 
Adolescents, Internet i Salut: riscos i oportunitats
Adolescents, Internet i Salut: riscos i oportunitatsAdolescents, Internet i Salut: riscos i oportunitats
Adolescents, Internet i Salut: riscos i oportunitatsManuel Armayones
 
Redes sociales como herramientas de alfabetización digital en salud:algunas b...
Redes sociales como herramientas de alfabetización digital en salud:algunas b...Redes sociales como herramientas de alfabetización digital en salud:algunas b...
Redes sociales como herramientas de alfabetización digital en salud:algunas b...Manuel Armayones
 
Alfabetización Digital en Salud: cuestión de "H-Alma"
Alfabetización Digital en Salud: cuestión de "H-Alma"Alfabetización Digital en Salud: cuestión de "H-Alma"
Alfabetización Digital en Salud: cuestión de "H-Alma"Manuel Armayones
 
¿Cómo pueden combinarse para ayudarnos a cambiar nuestro comportamiento hacia...
¿Cómo pueden combinarse para ayudarnos a cambiar nuestro comportamiento hacia...¿Cómo pueden combinarse para ayudarnos a cambiar nuestro comportamiento hacia...
¿Cómo pueden combinarse para ayudarnos a cambiar nuestro comportamiento hacia...Manuel Armayones
 
¿Que sabemos sobre la relación entre tecnología y personas?
¿Que sabemos sobre la relación entre tecnología y personas?¿Que sabemos sobre la relación entre tecnología y personas?
¿Que sabemos sobre la relación entre tecnología y personas?Manuel Armayones
 
Promoción de la Salud y Cambio de Hábitos: Retos permanentes en una sociedad ...
Promoción de la Salud y Cambio de Hábitos: Retos permanentes en una sociedad ...Promoción de la Salud y Cambio de Hábitos: Retos permanentes en una sociedad ...
Promoción de la Salud y Cambio de Hábitos: Retos permanentes en una sociedad ...Manuel Armayones
 
Psicologia 2.0. Retos y Oportunidades
Psicologia 2.0. Retos y OportunidadesPsicologia 2.0. Retos y Oportunidades
Psicologia 2.0. Retos y OportunidadesManuel Armayones
 
Innovación en investigación en Enfermedades Raras: ePacibard. Inteligencia Co...
Innovación en investigación en Enfermedades Raras: ePacibard. Inteligencia Co...Innovación en investigación en Enfermedades Raras: ePacibard. Inteligencia Co...
Innovación en investigación en Enfermedades Raras: ePacibard. Inteligencia Co...Manuel Armayones
 
Medicine20 stanford armayones
Medicine20 stanford armayonesMedicine20 stanford armayones
Medicine20 stanford armayonesManuel Armayones
 
Presentation valencia roundtable
Presentation valencia roundtablePresentation valencia roundtable
Presentation valencia roundtableManuel Armayones
 
Tromso Telemedicine Laboratory (TROMSO) Marathon Projects
Tromso Telemedicine Laboratory (TROMSO) Marathon ProjectsTromso Telemedicine Laboratory (TROMSO) Marathon Projects
Tromso Telemedicine Laboratory (TROMSO) Marathon ProjectsManuel Armayones
 
Armayones congreso cronicos_2011
Armayones congreso cronicos_2011Armayones congreso cronicos_2011
Armayones congreso cronicos_2011Manuel Armayones
 
Algunas reflexiones sobre el futuro de la eSalud
Algunas reflexiones sobre el futuro de la eSaludAlgunas reflexiones sobre el futuro de la eSalud
Algunas reflexiones sobre el futuro de la eSaludManuel Armayones
 
Social Media&Rare Diseases
Social Media&Rare DiseasesSocial Media&Rare Diseases
Social Media&Rare DiseasesManuel Armayones
 
Online communities as a vehicle to improving interactions between patients an...
Online communities as a vehicle to improving interactions between patients an...Online communities as a vehicle to improving interactions between patients an...
Online communities as a vehicle to improving interactions between patients an...Manuel Armayones
 

Plus de Manuel Armayones (20)

Behavior Design Lab-eHealth Center-Open University of Catalonia
Behavior Design Lab-eHealth Center-Open University of CataloniaBehavior Design Lab-eHealth Center-Open University of Catalonia
Behavior Design Lab-eHealth Center-Open University of Catalonia
 
Adolescents, Internet i Salut: riscos i oportunitats
Adolescents, Internet i Salut: riscos i oportunitatsAdolescents, Internet i Salut: riscos i oportunitats
Adolescents, Internet i Salut: riscos i oportunitats
 
Redes sociales como herramientas de alfabetización digital en salud:algunas b...
Redes sociales como herramientas de alfabetización digital en salud:algunas b...Redes sociales como herramientas de alfabetización digital en salud:algunas b...
Redes sociales como herramientas de alfabetización digital en salud:algunas b...
 
Alfabetización Digital en Salud: cuestión de "H-Alma"
Alfabetización Digital en Salud: cuestión de "H-Alma"Alfabetización Digital en Salud: cuestión de "H-Alma"
Alfabetización Digital en Salud: cuestión de "H-Alma"
 
¿Cómo pueden combinarse para ayudarnos a cambiar nuestro comportamiento hacia...
¿Cómo pueden combinarse para ayudarnos a cambiar nuestro comportamiento hacia...¿Cómo pueden combinarse para ayudarnos a cambiar nuestro comportamiento hacia...
¿Cómo pueden combinarse para ayudarnos a cambiar nuestro comportamiento hacia...
 
¿Que sabemos sobre la relación entre tecnología y personas?
¿Que sabemos sobre la relación entre tecnología y personas?¿Que sabemos sobre la relación entre tecnología y personas?
¿Que sabemos sobre la relación entre tecnología y personas?
 
Promoción de la Salud y Cambio de Hábitos: Retos permanentes en una sociedad ...
Promoción de la Salud y Cambio de Hábitos: Retos permanentes en una sociedad ...Promoción de la Salud y Cambio de Hábitos: Retos permanentes en una sociedad ...
Promoción de la Salud y Cambio de Hábitos: Retos permanentes en una sociedad ...
 
Psicologia 2.0. Retos y Oportunidades
Psicologia 2.0. Retos y OportunidadesPsicologia 2.0. Retos y Oportunidades
Psicologia 2.0. Retos y Oportunidades
 
Innovación en investigación en Enfermedades Raras: ePacibard. Inteligencia Co...
Innovación en investigación en Enfermedades Raras: ePacibard. Inteligencia Co...Innovación en investigación en Enfermedades Raras: ePacibard. Inteligencia Co...
Innovación en investigación en Enfermedades Raras: ePacibard. Inteligencia Co...
 
Medicine20 stanford armayones
Medicine20 stanford armayonesMedicine20 stanford armayones
Medicine20 stanford armayones
 
Presentation valencia roundtable
Presentation valencia roundtablePresentation valencia roundtable
Presentation valencia roundtable
 
Medicine20 Stanford
Medicine20 StanfordMedicine20 Stanford
Medicine20 Stanford
 
Tromso Telemedicine Laboratory (TROMSO) Marathon Projects
Tromso Telemedicine Laboratory (TROMSO) Marathon ProjectsTromso Telemedicine Laboratory (TROMSO) Marathon Projects
Tromso Telemedicine Laboratory (TROMSO) Marathon Projects
 
Armayones congreso cronicos_2011
Armayones congreso cronicos_2011Armayones congreso cronicos_2011
Armayones congreso cronicos_2011
 
Algunas reflexiones sobre el futuro de la eSalud
Algunas reflexiones sobre el futuro de la eSaludAlgunas reflexiones sobre el futuro de la eSalud
Algunas reflexiones sobre el futuro de la eSalud
 
Social Media&Rare Diseases
Social Media&Rare DiseasesSocial Media&Rare Diseases
Social Media&Rare Diseases
 
Presentación armayones
Presentación armayonesPresentación armayones
Presentación armayones
 
E salud epacientes
E salud epacientesE salud epacientes
E salud epacientes
 
Online communities as a vehicle to improving interactions between patients an...
Online communities as a vehicle to improving interactions between patients an...Online communities as a vehicle to improving interactions between patients an...
Online communities as a vehicle to improving interactions between patients an...
 
Psinet Totana
Psinet TotanaPsinet Totana
Psinet Totana
 

Social Media-Rare Disease (Luis Luque, Manuel Armayones)

  • 1. How can things change? By implementing a comprehensive approach to rare diseases By developing appropriate public health policies By increasing international cooperation in scientific research By gaining and sharing scientific knowledge about all rare diseases, not only the most “frequent” ones By developing new diagnostic and therapeutic procedures By raising public awareness By facilitating the network of patient groups to share their experience and best practices By supporting the most isolated patients and their parents to create new patient communities or patient groups By providing comprehensive quality information to the rare disease community Source: Eurordis
  • 2. By implementing a comprehensive approach to rare diseases
  • 3.  
  • 4. By developing appropriate public health policies
  • 5.  
  • 6.  
  • 7. By gaining and sharing scientific knowledge about all rare diseases, not only the most “frequent” ones By developing new diagnostic and therapeutic procedures
  • 8.  
  • 9. By gaining and sharing scientific knowledge about all rare diseases, not only the most “frequent” ones By developing new diagnostic and therapeutic procedures
  • 10. By raising public awareness By facilitating the network of patient groups to share their experience and best practices
  • 11. By supporting the most isolated patients and their parents to create new patient communities or patient groups
  • 12. Thanks for your atention Thanks! More Questions???